Boyer talks to ABC News about generic Lipitor warning

By Jim Fessenden

UMass Medical School Communications

November 30, 2012

Ranbaxy Laboratories has halted production of its generic Lipitor while it explores how glass particles, the size of a grain of sand, got into ingredients used in the pills. More than four million American use the Ranbaxy generic form of Lipitor to control their cholesterol.

UMass Medical School Professor of Emergency Medicine Edward Boyer, MD, PhD, was the featured expert on ABC’s World News Tonight and Good Morning America, where he talked about the potential health risks to patients and Ranbaxy’s ongoing quality control problems.

“This is not truly a threat to people’s health," Dr. Boyer said. "Eating a pill that contains numerous particles of glass a millimeter in size or less is akin to eating a pill that contains small bits of sand in it."

“The company has real difficulties with quality control,” Boyer told ABC. “Not in one or a couple of its facilities, but in many of its facilities.”

Watch the full story at Good Morning America: Generic Lipitor Warning: Manufacturer Halts Production of Drug

Watch the full story at ABC World News Tonight: Generic Lipitor Warning: Manufacturer Halts Production of Drug